MJ's Kids Favor Janet

While Michael Jackson’s mom, Katherine Jackson continues to fend off Debbie Rowe over the issue of custody for the late King of Pop’s kids, it’s Michael’s sister Janet Jackson who has emerged in the eyes of many as the favored caregiver for the three children. And that appears to be just what Prince, Paris and Blanket want most.“All three want Janet to read to them at night,” a Jackson family friend says. “They just melt into her arms when she walks into the house.” The feeling is mutual, adds the insider.
more HERE

Related:
Michael Jackson's record sales top 9 million since his death
Michael Jackson's death has the FDA considering labeling Propofol a 'controlled substance'
DEA might tighten restrictions on sedative propofol

FDA Ordered to Rethink Plan B

A federal judge ordered the Food and Drug Administration yesterday to reconsider its 2006 decision to deny girls younger than 18 access to the morning-after pill Plan B without a prescription.
U.S. District Judge Edward R. Korman in New York instructed the agency to make Plan B available to 17-year-olds within 30 days and to review whether to make the emergency contraceptive available to all ages without a doctor's order.
In his 52-page decision, Korman repeatedly criticized the FDA's handling of the issue, agreeing with allegations in a lawsuit that the decision was "arbitrary and capricious" and influenced by "political and ideological" considerations imposed by the Bush administration.
Washington Post report HERE
t-shirt available HERE

Medicinal Goats

They have four legs, fuzzy faces and udders full of milk.
To the uninitiated, they look like dairy goats. To GTC Biotherapeutics Inc., they're cutting-edge drug-making machines.
A herd of goats has been genetically engineered to make a human protein in their milk that can prevent dangerous blood clots. If the drug is approved by the FDA, the barn door could swing open.
Los Angeles Times report HERE

FDA Lashes Out

Allergan Inc, the maker of Botox, said on Friday that the U.S. Food and Drug Administration has approved its eyelash-thickening drug Latisse.
The active ingredient in Latisse is bimatroprost, the same ingredient that is in Allergan's glaucoma treatment Lumigan. Patients taking Lumigan found a side effect of the drug to be eyelash growth, prompting Allergan to study it for the new use.
Latisse is a once-daily prescription treatment that is applied to the base of the upper eyelash with a sterile, single-use-per-eye disposable applicator. Once treatment is stopped, eyelashes will gradually return to where they were prior to treatment.
Reuters report HERE

FDA to approve 'Frankenfood'

Genetically engineered animals moved closer to the dinner table on Thursday as the U.S. Food and Drug Administration made the process it will use to review new proposals public.
The FDA published proposed detailed guidelines that producers of genetically engineered animals would have to follow to determine whether there are any risks to humans, the environment and the animals themselves.
Reuters report HERE

The comment period for the draft guidance, titled "The Regulation of Genetically Engineered Animals Containing Heritable rDNA Constructs," runs for 60 days and closes Nov. 18, 2008. The 25-page document is available online HERE